Kewaunee Scientific (KEQU) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access KEQU quarterly Cash Flow →
The data below summarizes Kewaunee Scientific's cash flow activity from Apr 30 2022 to Apr 30 2026, enabling a period-by-period view of cash movement.
Annual Report, GAAP in USD millions
ITEM
(Apr 30 2026)
12 Months
(Apr 30 2025) (Apr 30 2024) (Apr 30 2023) (Apr 30 2022)
Operating Activities
Income10.47
Depreciation & amortization6.28
Amortization of Other Assets0.57
Increase (Decrease) in Deferred Revenue-1.92
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.34
Increase (Decrease) in Inventories-2.32
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation2.13
Income (Loss) from Equity Method Investments0.00
Paid-in-Kind Interest0.00
Provision For Deferred Income Taxes-
Increase Decrease In Contract With Customer Liability-2.20
Income taxes1.24
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-3.30
Increase (Decrease) in Accounts Payable and Accrued Liabilities-5.15
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Taxes0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.85
Payments for (Proceeds from) Other Operating Activities9.46
Discontinued operations0.00
Net Cash flow from Operating Activities18.63
Investing Activities
Capital Expenditures-3.94
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net-0.12
Discontinued operations0.00
Net Cash Flow from Investing Activities-3.94
Financing Activities
Short-term debt Net-0.91
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-18.08
Increase Decrease In Short Term Borrowings And Interest Rate Swap-
Net Proceeds From Exercise Of Stock Options Including Tax Benefit-
Proceeds From Financing Liability-
Payments On Financing Liability-0.77
Finance Lease Principal Payments-0.10
Payments of Ordinary Dividends, Noncontrolling Interest-0.34
Dividends paid0.00
Net Cash Flow from Financing Activities-19.33
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow14.70
Total Cash Flow-5.55
4 historic quarters locked

Sign in to unlock the full Kewaunee Scientific cash flow history.

About Kewaunee Scientific Corp Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0000055529-26-000020

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document





                    
Get the full CSIMarket dataset: Subscribe API License